Keyphrases
Xenograft Tumor
100%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Treatment Response
100%
Human Ovarian Cancer
100%
Carboplatin
100%
Paclitaxel
100%
SUVmax
33%
Tracer Uptake
22%
Ovarian Cancer
22%
PET Imaging
11%
Imaging Biomarkers
11%
Ki-67
11%
Non-responders
11%
First-line Chemotherapy
11%
Gene Expression
11%
Antitumor Effect
11%
Preclinical Animal Models
11%
18F-fluorothymidine
11%
Treatment Monitoring
11%
Positron Emission Tomography-computed Tomography (PET-CT)
11%
Glucose Transporter 1 (GLUT1)
11%
Glucose Uptake
11%
In Vivo Uptake
11%
Early Signal
11%
Cell Proliferation
11%
Fluorodeoxyglucose
11%
Early Response
11%
A2780
11%
Small Animal PET
11%
Treatment Initiation
11%
FDG-PET Scan
11%
Prolonged Response
11%
Optimal Timing
11%
Tumor
11%
Transient Signal
11%
Medicine and Dentistry
Neoplasm
100%
Polyethylene Terephthalate
100%
Paclitaxel
100%
Tumor Xenograft
100%
Treatment Response
100%
Carboplatin
100%
Ovarian Cancer
100%
Radioactive Tracer
22%
Gene Expression
11%
Glucose Transporter 1
11%
Positron Emission Tomography-Computed Tomography
11%
Biological Marker
11%
Fluorodeoxyglucose F 18
11%
positron emission tomographic scan
11%
Glucose Uptake
11%
Cell Proliferation
11%
First-Line Chemotherapy
11%
Fluorine-18
11%